People diagnosed with “personality disorders” are likely to also experience alcohol problems.
Dean Connolly summarises a recent systematic review that confirms the very high prevalence of comorbid personality disorders and alcohol use disorders.
[read the full story...]
Eloise Stark looks at a recent online survey which seeks to understand psychiatrists’ knowledge, attitudes and experiences in identifying and supporting their patients on the autism spectrum.
[read the full story...]
Camille Hart and Iain McDougall explore a recent narrative review by Jessica Yakeley and argue that psychodynamic psychotherapies should be made more widely available within UK mental health services.
[read the full story...]
Sally McManus writes her debut elf blog on a recent national cohort study of multiple adverse outcomes following first discharge from psychiatric care, which finds that mental health inpatients are more likely to experience all types of adversity after leaving hospital.
[read the full story...]
Ian Hamilton looks at a Swedish 42-year follow-up study, which looks at the impact that psychiatric comorbidity can have on premature death in a cohort of patients with substance use disorders.
[read the full story...]
Jodi Rintelman writes her debut elf blog on the first randomised controlled trial on the efficacy and safety of intranasal esketamine as an adjunctive treatment to antidepressants for treatment-resistant depression.
[read the full story...]
Bethany Gill helps us prepare for the #MentalHealthCarers event by summarising a service evaluation of a peer-led psychoeducation programme which aims to improve mental health carers well-being, reduce burden and enrich empowerment.
[read the full story...]
Benjamin Janaway blogs about a major data analysis that links adolescent cannabis use with increased risk of depression and suicide. He considers the opportunities for early recognition of cannabis use and public intervention.
[read the full story...]
A group of UCL Masters Students summarise a recent network meta-analysis of drug treatment for generalised anxiety disorder, which finds that Venlafaxine, Pregabalin, Escitalopram and Duloxetine are all viable alternatives to Benzodiazepines.
[read the full story...]
Samuele Cortese reports on a recent study of 13-25 year old people with ADHD, which looks at the comparative risk of psychosis during treatment with methylphenidate and amphetamines.
[read the full story...]
